Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (29)
Sarah Rouhana, Anne Virsolvy, Nassim Fares, Sylvain Richard & Jérôme Thireau. (2021) Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning. Pharmaceuticals 15:1, pages 31.
Crossref
Crossref
Daniel Gratz, Alexander J Winkle, Seth H Weinberg & Thomas J Hund. (2021) Statistical Approach to Incorporating Experimental Variability into a Mathematical Model of the Voltage-Gated Na+ Channel and Human Atrial Action Potential. Cells 10:6, pages 1516.
Crossref
Crossref
Meng Geng, Andrew Lin & Thao P. Nguyen. (2020) Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms. Frontiers in Pharmacology 11.
Crossref
Crossref
Richard L. Verrier & Luiz Belardinelli. (2020) Pulmonary Delivery of Antiarrhythmic Drugs for Rapid Conversion of New-Onset Atrial Fibrillation. Journal of Cardiovascular Pharmacology 75:4, pages 276-283.
Crossref
Crossref
Richard L. Verrier, Alexandre L. Bortolotto, Bruna A. Silva, Alexandre A. Marum, Fernando G. Stocco, Ederson Evaristo, Victor Z. de Antonio, Anderson C. Silva & Luiz Belardinelli. (2018) Accelerated conversion of atrial fibrillation to normal sinus rhythm by pulmonary delivery of flecainide acetate in a porcine model. Heart Rhythm 15:12, pages 1882-1888.
Crossref
Crossref
Victor Z. de Antonio, Anderson C. Silva, Fernando G. Stocco, Bruna A. Silva, Alexandre A. Marum, Alexandre L. Bortolotto, Luiz Belardinelli & Richard L. Verrier. (2018) Pulmonary delivery of flecainide causes a rate‐dependent predominant effect on atrial compared with ventricular depolarization duration revealed by intracardiac recordings in an intact porcine model. Journal of Cardiovascular Electrophysiology 29:11, pages 1563-1569.
Crossref
Crossref
Dan Hu, Hector Barajas-Martínez, Alexander Burashnikov, Brian K. Panama, Jonathan M. Cordeiro & Charles Antzelevitch. (2016) Mechanisms underlying atrial-selective block of sodium channels by Wenxin Keli: Experimental and theoretical analysis. International Journal of Cardiology 207, pages 326-334.
Crossref
Crossref
Kui-Hao Chen, Xiao-Hui Xu, Hai-Ying Sun, Xin-Ling Du, Hui Liu, Lei Yang, Guo-Sheng Xiao, Yan Wang, Man-Wen Jin & Gui-Rong Li. (2016) Distinctive property and pharmacology of voltage-gated sodium current in rat atrial vs ventricular myocytes. Heart Rhythm 13:3, pages 762-770.
Crossref
Crossref
Victoria M. RobinsonPeter R. Kowey. (2015) Smoothing the Bumpy Road to Antiarrhythmic Drug Development. Circulation 132:23, pages 2195-2197.
Crossref
Crossref
Antao LuoJihua MaYejia Song, Chunping QianYing WuPeihua ZhangLeilei WangChen FuZhenzhen CaoJohn C. Shryock. (2014) Larger late sodium current density as well as greater sensitivities to ATX II and ranolazine in rabbit left atrial than left ventricular myocytes. American Journal of Physiology-Heart and Circulatory Physiology 306:3, pages H455-H461.
Crossref
Crossref
Ursula Ravens, Claire Poulet, Erich Wettwer & Michael Knaut. (2013) Atrial selectivity of antiarrhythmic drugs. The Journal of Physiology 591:17, pages 4087-4097.
Crossref
Crossref
Alexander Burashnikov & Charles Antzelevitch. (2012) Role of Late Sodium Channel Current Block in the Management of Atrial Fibrillation. Cardiovascular Drugs and Therapy 27:1, pages 79-89.
Crossref
Crossref
Alexander Burashnikov & Charles Antzelevitch. 2013. Electrical Diseases of the Heart. Electrical Diseases of the Heart
141
156
.
Alexander Burashnikov, Hector Barajas-Martinez, Dan Hu, Eyal Nof, Jonathan Blazek & Charles Antzelevitch. (2012) Atrial-selective Prolongation of Refractory Period With AVE0118 is Due Principally to Inhibition of Sodium Channel Activity. Journal of Cardiovascular Pharmacology 59:6, pages 539-546.
Crossref
Crossref
Alexander BurashnikovMarc PourrierJohn K. GibsonJoseph J. LynchCharles Antzelevitch. (2012) Rate-Dependent Effects of Vernakalant in the Isolated Non-Remodeled Canine Left Atria Are Primarily Due to Block of the Sodium Channel. Circulation: Arrhythmia and Electrophysiology 5:2, pages 400-408.
Crossref
Crossref
A. Burashnikov, L. Belardinelli & C. Antzelevitch. (2011) Atrial-Selective Sodium Channel Block Strategy to Suppress Atrial Fibrillation: Ranolazine versus Propafenone. Journal of Pharmacology and Experimental Therapeutics 340:1, pages 161-168.
Crossref
Crossref
Jérôme Kalifa & Uma Mahesh R. Avula. (2012) The Chinese herb extract Wenxin Keli: Atrial selectivity from the Far East. Heart Rhythm 9:1, pages 132-133.
Crossref
Crossref
Alexander Burashnikov, Alyssa Petroski, Dan Hu, Hector Barajas-Martinez & Charles Antzelevitch. (2012) Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation. Heart Rhythm 9:1, pages 125-131.
Crossref
Crossref
Alexander Burashnikov & Charles Antzelevitch. (2011) Novel pharmacological targets for the rhythm control management of atrial fibrillation. Pharmacology & Therapeutics 132:3, pages 300-313.
Crossref
Crossref
Ge GaoAn XieShu-Ching HuangAnyu ZhouJianhua ZhangAmanda M. HermanSassan GhassemzadehEuy-Myoung JeongSrinivasan KasturiranganMihai RaicuMichael A. SobieskiIIIIGeetha BhatAntone TatoolesEdward J. BenzJrJrTimothy J. KampSamuel C. DudleyJrJr. (2011) Role of RBM25/LUC7L3 in Abnormal Cardiac Sodium Channel Splicing Regulation in Human Heart Failure. Circulation 124:10, pages 1124-1131.
Crossref
Crossref
Charles Antzelevitch, Alexander Burashnikov, Serge Sicouri & Luiz Belardinelli. (2011) Electrophysiologic basis for the antiarrhythmic actions of ranolazine. Heart Rhythm 8:8, pages 1281-1290.
Crossref
Crossref
Roman Bogdan, Heinz Goegelein & Hartmut Ruetten. (2011) Effect of dronedarone on Na+, Ca2+ and HCN channels. Naunyn-Schmiedeberg's Archives of Pharmacology 383:4, pages 347-356.
Crossref
Crossref
U. Ravens & E. Wettwer. (2010) Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications. Cardiovascular Research 89:4, pages 776-785.
Crossref
Crossref
Alexander Burashnikov & Charles Antzelevitch. (2011) Advances in the Pharmacologic Management of Atrial Fibrillation. Cardiac Electrophysiology Clinics 3:1, pages 157-167.
Crossref
Crossref
John C. Shryock. (2011) Role of Late Sodium Channel Current in Arrhythmogenesis. Cardiac Electrophysiology Clinics 3:1, pages 125-140.
Crossref
Crossref
U. Ravens & T. Christ. (2010) Atrial-selective drugs for treatment of atrial fibrillationVorhofselektive Antiarrhythmika für die Therapie von Vorhofflimmern. Herzschrittmachertherapie + Elektrophysiologie 21:4, pages 217-221.
Crossref
Crossref
Alexander Burashnikov, Serge Sicouri, José M. Di Diego, Luiz Belardinelli & Charles Antzelevitch. (2010) Synergistic Effect of the Combination of Ranolazine and Dronedarone to Suppress Atrial Fibrillation. Journal of the American College of Cardiology 56:15, pages 1216-1224.
Crossref
Crossref
Alexander Burashnikov, Andrew C Zygmunt, Jose M Di Diego, Gunilla Linhardt, Leif Carlsson & Charles Antzelevitch. (2010) AZD1305 Exerts Atrial Predominant Electrophysiological Actions and Is Effective in Suppressing Atrial Fibrillation and Preventing Its Reinduction in the Dog. Journal of Cardiovascular Pharmacology 56:1, pages 80-90.
Crossref
Crossref
Alexander Burashnikov & Charles Antzelevitch. (2010) New developments in atrial antiarrhythmic drug therapy. Nature Reviews Cardiology 7:3, pages 139-148.
Crossref
Crossref